bioRxivBiochemistryPreprint
Rapid in vitro synthesis of DNA templates via Sidewinder for polyadenylated Hantavirus mRNA vaccine candidates
Ezri AbrahamiD, Joel Andrade, Alexander Davis, Tomasz GawdaiD, Jacob Glanville, Daniel GravesiD, Jianyi HuangiD, Jeongsoo HuriD, Sangil KimiD, Jean-Sebastien PauliD, Noah Evan RobinsoniD, Charles SanfiorenzoiD, Sixiang WangiD, Raymond J. ZhangiD, Weilin Zhang, Tianhua ZhaoiD, Jie ZhouiD, Kaihang WangiD
Abstract
As the recent COVID-19 pandemic illustrated, zoonotic viruses and other pathogens pose a credible threat to public health. Recent advancements in vaccine technology, particularly mRNA vaccines, provide key tools for an effective and swift public health response. Although mRNA vaccines can be developed more quickly than traditional vaccines, fast and accurate construction of DNA templates for these vaccines remains a critical bottleneck. Using our novel DNA assembly technology, Sidewinder, we rapidly designed and built multiple mRNA vaccine candidates to guard against a potential outbreak of Hantavirus (ANDV). We successfully constructed the DNA templates from oligo pools and produced the mRNA for three vaccine candidates in just 2 days after delivery of the synthetic DNA oligos.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- mRNA Vaccines Induce Rapid Antibody Responses in Mice
M. Gebre, S. Rauch, … D. H. Barouch·bioRxiv·Nov 1, 2021
- Streamlined DNA template preparation and co-transcriptional 5' capped RNA synthesis enabled by solid-phase catalysis
G. G. Marquina, A. Zhang, … M.-Q. Xu·bioRxiv·Oct 28, 2023
- Accelerating manufacturing to start large-scale supply of a new adenovirus-vectored vaccine within 100 days
C. C. Joe, R. R. Segireddy, … A. Douglas·bioRxiv·Dec 22, 2021
- SARS-CoV-2 mRNA vaccine is re-adenylated in vivo, enhancing antigen production and immune response
P. S. Krawczyk, O. Gewartowska, … S. Mroczek·bioRxiv·Dec 1, 2022
- Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
K. V. Kalnin, T. Plitnik, … D. Casimiro·bioRxiv·Oct 14, 2020
- mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents